Jeff Simmons

Jeff Simmons Portrait

Since 2008, Jeff Simmons has served as president of Elanco, the animal health division of Eli Lilly and Company, (NYSE: LLY). As part of this role, he is also a Senior Vice President and Executive Officer of Lilly. Elanco is provides comprehensive products and knowledge services to improve animal health and food-animal production in more than 70 countries around the world. As a leading global animal health company, Elanco values innovation, both in scientific research and daily operations, and strives to cultivate a collaborative work environment for more than 6,500 employees worldwide through its vision of Food and Companionship Enriching Life.

In more than two decades with the company, Simmons has held a number of sales, marketing and management positions, in the United States and abroad, including:
 Executive Director of U.S. Operations, Global Strategy, and Research and Development
 Area Director, Western Europe, based in the U.K.
 Elanco Country Director, Brazil, based in Sao Paulo
 Global marketing director, cattle and poultry

These international experiences offered Simmons a new perspective on food and agriculture and created a deep conviction about the need for solutions to global food security.  Elanco is bringing this vision to life via a commitment to end hunger for 100,000 families globally through a partnership with Heifer International, and begin breaking the cycle of hunger in 100 communities around the globe. Simmons has become an active advocate for the role technology plays in sustainable, efficient production of safe, affordable meat, dairy and eggs.  He has published white papers on this topic, most recently, the ENOUGH report found at, and he actively engages in food security discussions in social media @JeffSimmons2050.  

Simmons has held numerous leadership positions, including past board member of Chiquita Brands and former president of Health for Animals (formerly IFAH).

Simmons grew up on a vineyard in upstate New York and holds a bachelor’s degree in agricultural economics from Cornell University. He resides in Carmel, Ind. with his wife, Annette, and six children.


Rob Aukerman
U.S. and Canada Operations

Rob Aukerman Portrait

Rob Aukerman has led the U.S. business since May 2007 and recently added Canadian operations.  

Since joining Elanco in 1992, Aukerman has held a number of senior management positions within the company, including director of innovation strategy, area director for the Pacific Rim and senior director of global marketing.

Aukerman earned a bachelor’s degree in psychology from Asbury College in 1981. After working for three years in his family’s dairy business and serving eight years in the feed industry, he joined Elanco, a division of Eli Lilly and Company.

Aukerman currently serves on the Board of Directors and Executive Committee of the Animal Health Institute and on the Children’s Organ Transplant Association (COTA) Board of Directors.

Rob and his wife, Betty, have ten children and reside near Indianapolis, IN.


Ramiro Cabral
Regional Leader, Europe, Middle East and Africa (EMEA)

Ramiro Cabral Portrait

Ramiro Cabral is the Regional Leader for Europe, Middle East and Africa at Elanco Animal Health. In this capacity since Jun 2014, he is responsible for Elanco Business in the region.

Since joining Elanco in 1998, Dr. Cabral has held a number of management positions within the company, including Technical Sales at Elanco Argentina, Global Marketing Manager, Business Unit Director in the US Affiliate, and Affiliate Director at Elanco Canada.

Dr. Cabral earned a DVM degree at UNICEN, Argentina in 1995 and an MBA from Purdue University in 2005. After working for years in his family’s farm and working as a consultant in the Veterinary and Agribusiness industry, he joined the Elanco Division of Eli Lilly and Company.

Ramiro and his wife, Cecilia, reside in Antwerp, Belgium.

Tony Ezell
Chief Marketing Officer

Tony Ezell Portrait

Tony Ezell is the Chief Marketing Officer for Elanco. Responsible for all aspects of marketing Elanco’s existing and new products and brands, he has held this role since June 2014. Ezell joined Lilly in 1992, and over his 22 years has held many roles in sales, marketing and general management.  From 1999 to 2007, Ezell held various leadership positions within Eli Lilly including executive director of marketing for the endocrine business unit, as well as business unit leader of the US acute care business.

In more recent years Ezell has been a leader in Lilly’s market research organization where he  served as executive director of market research for Lilly USA; vice president, global market research; and chief customer officer.  As chief customer officer, he was responsible for leading Lilly’s enterprise level customer experience strategy as well as delivering on Lilly’s marketing and market research capability strategy. His focus was on ensuring the company consistently connects innovative science with relevant customer experiences necessary to deliver on both our product and corporate brand promises.  

Ezell has global experience and a passion for developing deep customer understanding and translating that understanding into meaningful brand campaigns. He is experienced in leading major transformation that spans business units, functions and geographies.  

Born in Mobile, Alabama, Ezell has a degree in Business Administration from the School of Business and Industry (SBI) at Florida A & M University, an Executive Education Certificate from Wharton and a Masters in Business from the Kellogg School of Management at Northwestern University. 

Ezell is on the Board of Trustees for the Marketing Science Institute and the KPMG Healthcare Advisory Board.  He serves on the Leadership Advisory Council for Providence Cristo Rey High School and is the Chairman of the UNCF Indiana Leadership Council. Ezell served on the Board of Directors for the Health Forum, LLC from 2006-2012.

Ralph Heuser
Regional Leader - Asia Pacific

Ralph Heuser Portrait

Ralph Heuser currently serves as Region Leader for Asia Pacific. He first worked for Pfizer, starting in 1994, as regional Key Account Manager, where he spent much time on the road and with customers. He says his company car became his office and the intense customer interaction benefited him a lot in later positions in sales, marketing and management.
Ralph then moved to become a Farm Animal Business Product Manager for Boehringer in 1996 and later joined Novartis as Head Marketing and Sales for the Human Medical Nutrition business (now part of Nestlé). During more than 18 years with Novartis and Novartis Animal Health he served in management positions for various countries in Central Europe as well as in Germany and Australia & New Zealand. Most recently, he held the role as Head of Global Sales Excellence and was appointed Head of Region Europe in 2013.
Ralph studied agricultural economics at the University in Bonn, Germany and received a doctorate in macroeconomics from the same university.

Jose Cardenas
Regional Leader - Latin America

Jose Cardenas Portrait

Jose Cardenas currently serves as the Regional Leader for Latin America at Elanco Animal Health. He began his career at Elanco in 1990 as a chemist and transitioned to sales and marketing in 1995.  
Jose has held various roles in the sales and marketing area including:  sale representative for cattle and swine, training and development associate, affiliate marketing director and global marketing director for all food animal species.   
Jose earned his bachelor’s degree in chemistry from Manchester College in May of 1989. He also holds a master’s in Business from Butler University.

Matthias Hofer
Emerging Business

Mattias Hofer Portrait

Since January of this year Matthias is responsible for 3 business areas within Elanco which together form Emerging Business. These business areas include Vaccines, Enzymes and Aquahealth.
From May 2014 to December 2014 Matthias was responsible for integration planning activities from a Novartis Animal Health perspective in relation to the EAH acquisition.
Matthias joined NAH in Australia in 2004. After working in Global Strategy in Basel for two years he was appointed Global Head of Strategy NAH in 2008.
In 2009 Matthias took on the role of Head Aqua Europe. In 2011 the Aqua Business became a business unit within Novartis AH and Matthias was promoted to Global Head of Aqua and at the same time he also became a member of the Animal Health Executive Committee.
Matthias holds a Master’s degree in Business Administration and Economics from the University of St. Gallen, Switzerland with an emphasis on Entrepreneurship.
He is based in Basel, Switzerland and lives with his wife and his two young children in the eastern part of Switzerland.

Jose Simas
Regulatory/Market Access/Elanco Knowledge Solutions

Dr. Jose Simas joined Elanco in 2000 in Brazil where he held a technical role for cattle products. He moved to global marketing in a technical support role in 2002 and moved to the United States.  In 2004, Simas took on the responsibility for the Argentina and Chile operations.  In late 2005, he moved to Vienna, Austria to serve as area director for Elanco’s operations in Central-Eastern Europe/North Africa/Middle Eastern markets. Simas also led the U.S. beef business from 2008 to 2011. Dr. Jose Simas most recently was responsible for the Companion Animal and Food Animal Product Development teams, as well as R&D operations.

Simas received a bachelor’s from the Federal University of Lavras in Brazil. He also holds a master’s and a doctorate in Animal Nutrition and Physiology from the University of Arizona, USA, as well as a post doctorate from the University of Sao Paulo, Brazil.

Leila Schwery

Leila Schwery Portrait

Leila started her career as a safety consultant for the chemical and pharmaceutical industry. She joined Novartis in 2003 as a Production Chemist (API manufacturing) in multipurpose production in Schweizerhalle, Switzerland. She then held roles of increasing responsibilities within Novartis Pharma TechOps Switzerland and Ireland, and was Site Head for Novartis Pharmaceutical Operations in Wehr, Germany.
Leila is a qualified Chemical Engineer from the Swiss Federal Institute of Technology (EPFL) in Switzerland and has a post graduate diploma in Safety Engineering.

John Kuckelman

John Kuckelman Portrait

John F. Kuckelman is General Counsel at Elanco Animal Health.   In his role, John leads the global legal team, which has responsibilities for the legal affairs of Elanco around the world.

Prior to assuming his current role in August 2014, John was Eli Lilly and Company’s General Counsel for Asia Operations, and was based in Hong Kong, China.  John also previously served as Lilly’s Global Anti-Corruption Counsel for four years.  Before joining Lilly in August 2007, John was a partner at Shook, Hardy & Bacon, where he defended pharmaceutical companies in litigation throughout the United States.  

John earned his Juris Doctor from the Notre Dame Law School, magna cum laude, in 1999, where he studied international law at Notre Dame’s London Law Centre.  From 1995-96, John was a Rotary Ambassadorial Fellow at Eberhard-Karls Universitaet Tuebingen, in Tuebingen, Germany where he pursued graduate studies in Government and History.  John earned his B.A. in history and political science from Washburn University in 1994.  John is a native of Atchison, Kansas.  He is married to Melissa Martinek Kuckelman and they have two children, Jack and Mary Margaret, and reside in Indianapolis, Indiana.

Eric Graves
Novartis Integration

Eric Graves Portrait

Eric Graves joined Elanco, the animal health division of Eli Lilly and Company in 2003 and has held a range of roles and responsibilities.  Eric is passionate about building teams and businesses, as well as applying a practical focus to bringing customers value.

Prior to his current role, he was Elanco’s Chief Marketing Officer and was responsible for all aspects of marketing for Elanco’s existing and new products and brands.  

Previously, he led Elanco’s launch into the companion animal market, where he enjoyed being part of building a team and business that created growth and value for customers. Part of this time he was based in Europe, working on the global companion animal health business with additional emphasis on integrating a previous acquisition and accelerating growth of the European companion animal business. 

Prior to joining Elanco, Eric served as director of veterinary marketing at Hill’s Pet Nutrition, Inc., a division of Colgate-Palmolive. He has also held a variety of positions in companion animal marketing, sales and operations at both Merial and Merck Agvet. 

Eric serves on the board of the Banfield Charitable Trust, an organization dedicated to keeping pets and their people together when facing challenging situations.

Eric earned degrees in marketing and science from Pennsylvania State University. He has received executive training from Columbia University in marketing management and from the Wharton School of Business in new product development.

Steve Jenison

Steve Jenison Portrait

Stephen H. Jenison  oversees internal manufacturing operations at facilities in the United States, Britain, and Ireland.  In addition, he oversees Elanco’s global external manufacturing operations and supply chain organization.

Born in Paris, Illinois, Jenison was awarded a Bachelor of Science degree in chemical engineering from Rose-Hulman Institute of Technology in 1981, and a master in business administration from the University of Kansas in 1985.

Jenison joined Lilly in 1986 as a technical service representative in Clinton Laboratories. He also held positions at Clinton as financial analyst and department head of chemical operations prior to becoming manager - North East Regional distribution center in Enfield, Connecticut in 1990. In 1991, he was named the development projects manager in LRL for Gemzar. Jenison moved to Puerto Rico in 1992 as the Mayaguez site head.  In 1995 he returned to various manufacturing strategy roles with the global business units and product teams.  Prior to becoming the senior manufacturing business lead for the Global Business Integration Project (GBIP) he had a short stint as Executive Director for the Indianapolis Pharmaceutical Operations.  From 2004-2009 Steve was the Vice President and Manufacturing Information Officer for Global Manufacturing.  In 2010, he began a dual reporting relationship to both Myles O’Neill, Senior Vice President of Global Drug Product and Jacques Tapiero, President of Emerging Markets.  During that position he served as the Vice President of Emerging Markets and External Drug Product Operations.  Prior to joining Lilly, Jenison held various positions in the inorganic chemicals industry.

Jade Kas
Human Resources

Jade Kas Portrait

Jade Kas was named to his current position in April 2013. He joined Eli Lilly and Company in 1999 and spent his first 4 yrs in both a sales and sales operations roles.

During the past 10 years, he has held a variety of roles in Human Resources supporting sales and marketing, global compensation, mergers and acquisitions, employee relations, and manufacturing. In his most recent role, Jade has been supporting Elanco as the Sr. Director of HR for Elanco Mfg.

Jade holds a bachelor's degree in Business Management & HR Management from IUPUI.

Brian Kopp
CFO / Strategy and Operations

Brian Kopp Portrait

Since 2007, Brian Kopp has served as CFO of Elanco. Mr. Kopp has been with Eli Lilly and Company for 17 years, holding a variety of positions, including:

  • Director and senior director of finance, Lilly USA Pharmaceutical Operations
  • Manager of corporate strategy and planning
  • Senior analyst, corporate finance and investment banking

Before joining Eli Lilly and Company, Mr. Kopp worked in various financial roles at General Motors Corp., including capital planning and manufacturing, as well as international treasury and business development support, primarily focused on Latin America.

Mr. Kopp sits on the Investment Committee of Lynx Capital Corp., a fund dedicated to providing growth capital to minority-owned businesses in Indiana.

He grew up in Northern Kentucky and Southern Indiana and holds a bachelor’s degree in finance from Indiana University and a master’s degree in business administration from Butler University.

Michael Morgan
Ethics and Compliance

Mike Morgan Portrait

Mike Morgan has worked for Eli Lilly in the pharmaceutical industry for 27+ years and for Elanco since September 2013.  Prior to his current role, Mike was the Senior Director of Ethics and Compliance for Europe, Canada and Australia from 2009-2013 and was Director of Ethics and Compliance at the Lilly Corporate Headquarters and in the US affiliate in Indianapolis, from 2005 to 2009.  Mike has worked in a variety of other functions within Lilly including Sales/Sales Management, Marketing/Pricing, Health Economics/Health Outcomes and worked at PCS Health Systems in Disease Management.
Education:   Bachelor of Science, Molecular and Cell Biology, Pennsylvania State University  
Master of Science, Business Management, Purdue University
Certifications:  Health Care Compliance Certification Seton Hall University Law School
Certified Compliance and Ethics Professional, Society of Corporate Compliance and Ethics

Aaron Schacht
Research and Development

Mr. Aaron Schacht is currently the Vice President for Global Research and Development at Elanco Animal Health.

Prior to this, Mr. Aaron Schacht held a role of Global Brand Development Leader – Pain in Lilly Biomedicines.  He was the global leader for product development and commercialization activities for LY2951742 – Lilly’s novel CGRP neutralizing antibody – a new potential treatment for prevention of Migraine and Cluster Headache.  In 2012, Schacht joined Lilly Biomedicines as Senior Advisor – Strategy & Business Development for Lilly BioMedicines.  His responsibilities included oversight of Therapeutic Strategy development, R&D Portfolio Management, and Business Development for Lilly BioMedicines – Lilly’s largest business unit.  

Past roles included serving as Executive Director, Global External R&D, at Eli Lilly and Company, where he was responsible for implementation of strategies which aim to leverage novel approaches to external partnerships to augment Lilly’s access to pharmaceutical innovation as well as Executive Director of LRL (Lilly Research Labs) Strategy, Portfolio Management and Project Management where he was responsible for strategic planning, R&D portfolio and project management.  Prior to these roles, he was Director, Innovation Center in the eLilly organization where he focused on the exploration, incubation and implementation of new business models and capabilities relevant to the strategic evolution of the pharmaceutical industry.  In 2002, during a short leave from Lilly, Mr. Schacht was co-founder, President and CEO of Artesian Therapeutics, a Gaithersburg, MD cardiovascular drug discovery start-up.

Previously, Mr. Schacht held roles as Managing Director of Lilly University, Director of Knowledge Management, and Manager of Strategy and Productivity for Discovery Research.

Mr. Schacht began his career at Lilly in 1990 as a medicinal chemist, and spent 5 years in the laboratory working to discover pharmaceuticals to treat cardiovascular disorders.  Schacht studied Organic chemistry at the University of Illinois, receiving his Bachelors of Science degree in 1990.